EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunomodulatory Natural Products in Cancer Organoid-Immune Co-Cultures: Bridging the Research Gap for Precision Immunotherapy

Chang-Eui Hong, Su-Yun Lyu iD

International Journal of Molecular Sciences · 26.07.2025 · 26 (15) · 7247

DOI: 10.3390/ijms26157247 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.07.2025. Verfasst von Chang-Eui Hong und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Sunchon National University, Suncheon 57922, Republic of Korea. Hauptthemen laut MEDLINE: Organoids, Neoplasms, Biological Products, Immunotherapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 254 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural products demonstrate potent immunomodulatory properties through checkpoint modulation, macrophage polarization, and T cell/natural killer (NK) cell activation. While cancer organoid-immune co-culture platforms enable physiologically relevant modeling of tumor–immune interactions, systematic investigation of natural product immunomodulation in these systems remains entirely unexplored. We conducted a comprehensive literature analysis examining natural products tested in cancer organoids, immunomodulatory mechanisms from traditional models, technical advances in organoid-immune co-cultures, and standardization requirements for clinical translation. Our analysis reveals a critical research gap: no published studies have investigated natural product-mediated immunomodulation using organoid-immune co-culture systems. Even though compounds like curcumin, resveratrol, and medicinal mushroom polysaccharides show extensive immunomodulatory effects in two-dimensional (2D) cultures, and organoid technology achieves high clinical correlation for drug response prediction, all existing organoid studies focus exclusively on direct cytotoxicity. Technical challenges include compound stability, limited matrix penetration requiring substantially higher concentrations than 2D cultures, and maintaining functional immune populations in three-dimensional (3D) systems. The convergence of validated organoid-immune co-culture platforms, Food and Drug Administration (FDA) regulatory support through the Modernization Act 2.0, and extensive natural product knowledge creates unprecedented opportunities. Priority research directions include systematic screening of immunomodulatory natural products in organoid-immune co-cultures, development of 3D-optimized delivery systems, and clinical validation trials. Success requires moving beyond cytotoxicity-focused studies to investigate immunomodulatory mechanisms in physiologically relevant 3D systems, potentially unlocking new precision cancer immunotherapy approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsNeoplasmsBiological ProductsImmunotherapyImmunomodulationHumansCoculture TechniquesPrecision MedicineAnimalsEvidence Gaps

Stichwörter der Autor:innen

3D cell culturecancer organoidsimmunomodulationnatural productsprecision medicinetumor microenvironment

Substanzen

Biological Products

Autor:innen und Institutionen

  • College of Pharmacy, Sunchon National University, Suncheon 57922, Republic of Korea.
  • Smart Beautytech Research Institute, Sunchon National University, Suncheon 57922, Republic of Korea.
  • Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea.

ORCID-Profile: Su-Yun Lyu

Zitieren

APA

Hong, C. E., & Lyu, S. Y. (2025). Immunomodulatory Natural Products in Cancer Organoid-Immune Co-Cultures: Bridging the Research Gap for Precision Immunotherapy. International Journal of Molecular Sciences, 26(15), 7247. https://doi.org/10.3390/ijms26157247

Vancouver

Hong CE, Lyu SY. Immunomodulatory Natural Products in Cancer Organoid-Immune Co-Cultures: Bridging the Research Gap for Precision Immunotherapy. International Journal of Molecular Sciences. 2025;26(15):7247. doi:10.3390/ijms26157247

BibTeX
@article{Hong2025,
  author = {Hong, Chang-Eui and Lyu, Su-Yun},
  title = {Immunomodulatory Natural Products in Cancer Organoid-Immune Co-Cultures: Bridging the Research Gap for Precision Immunotherapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {15},
  pages = {7247},
  doi = {10.3390/ijms26157247}
}
Kostenlos starten →